Navigation Links
Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
Date:6/11/2008

GOTHENBURG, Sweden, June 11 /PRNewswire/ -- Cellectricon, a leading provider of screening solutions for drug discovery, today announced a new collaborative agreement with AstraZeneca. Under the agreement Cellectricon will provide AstraZeneca with two of its new groundbreaking high throughput platform, Dynaflow(R)HT, for ion channel screening.

Cellectricon and AstraZeneca formed and announced a collaboration in May 2006 aiming to find a solution to major bottlenecks in ligand gated ion channel screening. The results from this collaboration have successfully demonstrated the unique performance of Cellectricon's cell-based microfluidic screening platform. It has clearly demonstrated the opportunity to introduce the fully automated Dynaflow(R)HT System with unmatched level of stability and throughput while still delivering unique measurement data quality. The Dynaflow(R)HT System will be launched and commercially available in 2009.

"Collaborating with AstraZeneca has been most rewarding," says Jonas Ohlsson, CEO at Cellectricon. "Driven by solving bottlenecks in drug discovery, Cellectricon's strategy is to bring state-of-the-art products for drug discovery and research to the market through world-class customer collaborations."

"This collaboration aims to accelerate our efforts in ion channel drug discovery and has been very fruitful to date. We look forward to working with the Dynaflow@HT Systems and see the impact of their throughput and cost effectiveness," says Dr. Jan-Erik Nystrom, VP Local Discovery Research Area CNS & Pain Control, Sodertalje, Sweden.

"The strength of this platform is that it is based on many years of cutting-edge academic and industrial research in ion channel drug discovery. I am happy to see us taking a new step together with a leading partner in advancing it further," says Dr. Jon Sinclair, VP Research & Development at Cellectricon.

About Cellectricon

Cellectricon AB (

SOURCE Cellectricon AB
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Share Issue Gives Cellectricon SEK 89 Million to Continue its Rapid Market Expansion
2. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
3. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
4. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
5. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
6. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
7. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
8. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
9. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
10. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
11. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstC... ), a leading provider of tools and services for d...troduced Living Image 4.0 software for IVIS® ...ves the more than 800 Caliper IVIS systems current...ge 4.0 features advanced spectral unmixing tools t...
(Date:12/2/2009)..., MANILA, Philippines, Dec. 2 Sp...t growing green energy companies on the planet. Th...rue Green Planet,s President and Recycling Special...business for over 25 years, stated that Spectrum B...setting the stage for spectacular earnings because...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Report...port is available in its catalogue: ,, Drug Di...rends & Opportunities ,, http://www.repor...-A-Global-Update-of-Market-Trends--Opportunities.h...nd ongoing element of every pharmaceutical company...
(Date:12/2/2009)... , TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCa...PHM ) today reported completion of patient enrollm...Cotara® in patients with relapsed glioblastom...ncer. Cotara is a targeted monoclonal antibody li...ial new treatment for GBM. Cotara specifically ta...
Breaking Biology Technology:Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5
... PAREXEL International,Corporation (Nasdaq: PRXL...ovider, today announced that the Company is among ...ide of China. PAREXEL is a leader in providing,Asi...clinical development,to help biopharmaceutical com...vant ethnic data in the U.S., and save time and de...
... ALine increases microfabrication busi... reagent and diagnostics industry veteran , ...ne, Inc., a high-tech provider of rapid prototypin...ces, welcomes Roger Anderson, PhD, as the Vice Pre... entrepreneurial and business growth experience to...
...in, November 5 SALVAT announced today the,submiss...or CETRAXAL(R),(Ciprofloxacin 0.2% Otic Solution i... received on April 6, 2006, the FDA requested addi...ng, and controls (CMC)., SALVAT expects the FDA t...bmission, under which the FDA will seek to complet...
Other Biology Technology:PAREXEL Expands Pioneering Asian Ethnobridging Expertise 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 5ALine, Inc. Expands Management, Adding Roger Anderson, Ph.D., as VP of Operations 2SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2
(Date:12/3/2009)...ow in Antarctic snowmelt that occurred during the ...t strong positive phases for two main climate driv...(Southern Hemisphere Annular Mode), according to D...tmospheric Sciences at The City College of New Yor...toral faculty at the CUNY Graduate Center, added t...
(Date:12/2/2009)...ople who smoke their first cigarette within minute...ine, a by-product of nicotine when processed by th...f the number of cigarettes smoked. , "Since c...cancer, our results suggest that smokers who smoke...k for lung cancer," said researcher Joshua E. Musc...
(Date:12/2/2009)...beef, peanut butter, and other foods have done mor...od safety. They also are quietly fueling a boom in...ng new food safety regulations. That,s the topic o... Chemical & Engineering News , (C&EN) ACS, weekly...emsley and Senior Correspondent Marc Reisch point ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 1T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 2T System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines Adds Discharge Instructions 57786 3Osseon Receives CE Mark 57784 1Osseon Receives CE Mark 57784 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 1Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 2Allied Worlds Linda McSmith to Speak at Ohio Association of Ambulatory Surgery Centers Annual Meeting 57782 3
...ENO, Nev. It huffed and puffed, but the 82-ton-fo...nock down the straw house designed and built by Un... Darcey Donovan. , The full-scale, 14-by-14-foot...clay plaster walls, the way she builds them in Pak...ion/shaking than was recorded at the 1994 Northrid...
...e wolves on Isle Royale are suffering from genetic...nological University blame the extreme inbreeding ...nd National Park in northern Lake Superior. , Re...ence that inbreeding has caused genetic deteriorat...f Peterson and John Vucetich of Michigan Tech and ...
...NCIE, Ind. A new study in the The Journal of App... modify their workouts to avoid extensive muscle l...e Station (ISS). , The latest NASA-sponsored rese...e Laboratory (HPL) suggests that changes are neede...tronauts to improve their muscle performance while...
Other Biology News:Straw bale house survives violent shaking at earthquake lab 2Straw bale house survives violent shaking at earthquake lab 3Bone deformities linked to inbreeding in Isle Royale wolves 2Bone deformities linked to inbreeding in Isle Royale wolves 3Astronauts may need more intense workouts to maintain muscle fitness in space 2
Calf Liver tRNA from Novagen
Rat Anti-B7 RP1 Monoclonal Antibody, Biotin Conjugated, Clone HK5.3 from Abcam
Rabbit Anti-ZFP200 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-BACE/Asp2 (CT) Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Biology Products: